One of the objectives of post-marketing trials of a coronavirus vaccine is to study volunteers over 60 years old. This was announced on Wednesday, September 2, by the director of the Gamaleya Center, Alexander Gintsburg.
“I think that when the post-registration tests start, one of the tasks of the post-registration tests, which will begin in the next five, six, seven days, will be research and groups of volunteers who are over sixty, 60, 70, 80 years old. Groups of volunteers will be recruited among Muscovites. “, – said Gunzburg in a conversation with RIA Novosti.
He expressed the hope that scientists will soon receive official permission to conduct trials of the vaccine on elderly people and noted that all participants will be under the close scrutiny of doctors.
According to him, doctors will not hospitalize volunteers, but will take tests from them before and after the study and will electronically monitor patients so that they can report their condition at any time.
On the eve of Gunzburg said that the vaccination of volunteers against coronavirus in Moscow will begin on September 5-7, writes Gazeta.ru.
On August 11, Russia registered the world’s first vaccine against COVID-19 under the name Sputnik V. Russian President Vladimir Putin assured that the coronavirus vaccine, developed by specialists from the Gamaleya Center, was registered in accordance with Russian laws and world practice.